# Lansoprazole in Preterm Infants With Reflux

> **NCT01778101** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 5 (actual)

## Conditions studied

- Preterm Infants
- Gastrointestinal Reflux

## Interventions

- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT01778101
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01778101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01778101, "Lansoprazole in Preterm Infants With Reflux". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01778101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*